v3.19.3.a.u2
Consolidated Statement of Shareholders' Investment - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Increase (Decrease) in Shareholders' Investment              
Beginning of Year   $ 30,722     $ 30,722    
Net Earnings $ 1,049 672 $ 654 $ 418 3,687 $ 2,368 $ 477
Other comprehensive income (loss)         (879) (1,192) 1,052
End of Year 31,301   30,722   31,301 30,722  
Common Shares:              
Increase (Decrease) in Shareholders' Investment              
Beginning of Year   23,512   23,206 23,512 23,206 13,027
Issued under incentive stock programs         209 163 242
Issued for St. Jude Medical acquisition             9,835
Share-based compensation         521 479 406
Issuance of restricted stock awards         (389) (336) (304)
End of Year 23,853   23,512   23,853 23,512 23,206
Common Shares Held in Treasury:              
Increase (Decrease) in Shareholders' Investment              
Beginning of Year   (9,962)   (10,225) (9,962) (10,225) (10,791)
Issued under incentive stock programs         361 408 400
Issued for St. Jude Medical acquisition             180
Purchased         (546) (145) (14)
End of Year (10,147)   (9,962)   (10,147) (9,962) (10,225)
Earnings Employed in the Business:              
Increase (Decrease) in Shareholders' Investment              
Beginning of Year   24,560   23,978 24,560 23,978 25,565
Impact of adoption of new accounting standards     351     351  
Net Earnings         3,687 2,368 477
Cash dividends declared on common shares         (2,343) (2,047) (1,947)
Effect of common and treasury share transactions         (57) (90) (117)
End of Year 25,847   24,560   25,847 24,560 23,978
Accumulated Other Comprehensive Income (Loss):              
Increase (Decrease) in Shareholders' Investment              
Beginning of Year   (7,586)   (6,062) (7,586) (6,062) (7,263)
Impact of adoption of new accounting standards     (332)     (332)  
Business dispositions             149
Other comprehensive income (loss)         (879) (1,192) 1,052
End of Year (8,465)   (7,586)   (8,465) (7,586) (6,062)
Noncontrolling Interests in Subsidiaries:              
Increase (Decrease) in Shareholders' Investment              
Beginning of Year   $ 198   $ 201 198 201 179
Noncontrolling Interests' share of income, business combinations, net of distributions and share repurchases         15 (3) 22
End of Year $ 213   $ 198   $ 213 $ 198 $ 201